Hu CD56 BV480 NCAM16.2 25Tst产品图

Hu CD56 BV480 NCAM16.2 25Tst

收藏
  • ¥3327
  • BD
  • 美国
  • 566162
  • 2026年10月23日
  • Flow Cytometry (FCM)
  • Mouse
  • Human
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商:

      BD Pharmingen

    • 靶点:

      CD56 (NCAM-1)

    • 级别:

      RUO

    • 克隆性:

      单克隆

    • 抗原来源:

      Human

    • 抗体英文名:

      CD56 (NCAM-1) Antibody

    • 抗体名:

      CD56 (NCAM-1)

    • 标记物:

      BV480

    • 宿主:

      Mouse

    • 适应物种:

      Human

    • 免疫原:

      Immunoaffinity-enriched adult human brain NCAM

    • 亚型:

      Mouse BALB/c IgG2b, κ

    • 形态:

      液体

    • 应用范围:

      Flow Cytometry (FCM)

    • 保存条件:

      2-8℃避光保存

    • 规格:

      25 Tests

    产品概述

    Hu CD56 BV480 NCAM16.2 25Tst 为 BD Pharmingen 品牌流式抗体,货号 566162,靶向 CD56 (NCAM-1),荧光标记 BV480,克隆 NCAM16.2 (also known as NCAM 16) (RUO),规格 25 Tests。适用于 Flow cytometry (Routinely Tested) 检测,仅供科研使用(RUO)。

    靶点与抗体说明

    The NCAM16.2 monoclonal antibody specifically binds to human CD56. It recognizes an extracellular immunoglobulin-like domain common to 120, 140, and 180 kDa forms of CD56, also known as the neural cell adhesion molecule (NCAM), NKH1 or MSK39. The CD56 antigen is expressed on approximately 10% to 25% of peripheral blood lymphocytes. It is present on essentially all resting and activated CD16+ natural killer (NK) lymphocytes and approximately 5% of CD3+ peripheral blood lymphocytes. CD3+ CD56+ T lymphocytes comprise a unique subset of cytotoxic T lymphocytes that mediates non-major histocompatibility complex (MHC)-restricted cytotoxicity. CD56 antigen density on NK lymphocytes increases upon cellular activation. The CD56 antigen is involved in neuronal homotypic cell adhesion and cell differentiation during embryogenesis. CD16+ CD56+ NK cells demonstrate reciprocal transfer of an activation state with dendritic cells. The antibody was conjugated to BD Horizon BV480 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 436-nm and Em Max at 478-nm, BD Horizon BV480 can be excited by the violet laser and detected in the BD Horizon BV510 (525/40-nm) filter set.  BV480 has less spillover into the BV605 detector and, in general, is brighter than BV510.

    核心参数

    货号 566162
    品牌 BD Pharmingen
    克隆号 克隆 NCAM16.2 (also known as NCAM 16) (RUO)
    宿主 Mouse
    同种型 Mouse BALB/c IgG2b, κ
    荧光标记 BV480
    抗原 / 靶点 CD56 (NCAM-1)
    反应种属 Human
    验证应用 Flow cytometry (Routinely Tested)
    推荐用量 5 µl
    免疫原 Immunoaffinity-enriched adult human brain NCAM
    规格 25 Tests
    存储缓冲液 Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

    荧光染料信息

    BV480 The BD Horizon Brilliant Violet™ 480 (BV480) Dye is part of the BD Horizon Brilliant Violet™ family of dyes. This polymer-technology fluorochrome has an excitation maximum (Ex Max) of 440-nm and an emission maximum (Em Max) of 479-nm. Driven by BD innovation, BV480 is designed to be excited by the violet laser (405-nm) and detected using an optical filter centered near 480-nm (e.g., a 525/50 bandpass filter). The increased fluorescence intensity of BV480 and narrower emission spectra, make it a good alternative for BV510 or V500. Due to its excitation profile, BV480 will also has less cross-laser excitation with the UV laser, resulting in less spillover into UV channels compared to BV510. Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye. 格式:BV480最多激发源:440 nm最多发射源:479 nm

    保存与运输

    建议 2-8℃ 避光保存,请勿冷冻,避免反复冻融。 存储缓冲液:Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

    参考文献

    Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med. 1996; 184(5):1845-1856. (Biology). Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001; 166(11):6477-6482. (Biology). Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer–cell subsets. Trends Immunol. 2001; 22(11):633-640. (Biology). Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman GM. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987; 236(4803):799-806. (Biology). Edelman GM. Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol. 1986; 2:81-116. (Biology). Galandrini R, Tassi I, Mattia G, et al. SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood. 2001; 100(13):4581-4589. (Biology). Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002; 195(3):327-333. (Biology). Lanier LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol. 1991; 146(12):4421-4426. (Immunogen: ELISA, Flow cytometry). Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986; 136(12):4480-4486. (Biology). Lanier LL, Testi R, Bindl J, Phillips JH. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med. 1989; 169(6):2233-2238. (Biology). Nitta T, Yagita H, Sato K, Okumura K. Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer–target cell interaction. J Exp Med. 1989; 170(5):1757-1761. (Biology). Phillips JH, Lanier LL. Dissection of the lymphokine-activated killer phenomenon: relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med. 1

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 对外周血中人自然杀伤(NK)细胞群的表型表征分析

      -CD56,圈选 CD56hi/CD16lo 和 CD56lo/CD16+ 细胞;针对每个 NK 细胞子集(CD56 hi/CD16lo 和 CD56lo/CD16+)显示以下图区:c-kit-CD38、CD57-CD11c,以及 CD57-CD8。7. 在培养基中运行样品。8. 自动调整,实现缩放。9. 获取 25 万至 50 万个 events。10. 调节补偿值。11. 保存数据。12. 导出至 FCS。13. 通过 Kaluza 进行分析。结论:NK 细胞与自身免疫病相关,并可能在 T

    • 血管里的“斑块清洁工”来了!CD25+调节性T细胞变身CAR-Treg,效果惊人

      4)[15-18]。目前对CD4+CD25+Tregs的效应机制还不十分明确。最初的体外研究明确支持CD4+CD25+Tregs是通过与其他细胞直接接触发挥抑制作用这一观点。因此,细胞-细胞互相接触是该亚型发挥作用的先决条件。 图4. IL-10和TGF-β参与CD4+CD25+Treg(iTREG)的免疫调节作用机制 [16] 4. CD4+CD25+Tregs在多种疾病中的作用 IL2RA,即DC25,主要表达于CD4+CD25+Tregs细胞表面。CD

    • 恶性肿瘤病人外周血免疫指标的流式细胞仪检测及免疫治疗前后免疫功能变化的研究

      ,其中年龄和性别构成比与病人组差异无显著性(P>0.05)。 1.2  材料与仪器  小鼠抗人单克隆抗体CD4/CD8/CD3、CD19、CD20、CD3/CD16+56、CD3/HLA-DR、CD3/CD25及同型对照、红细胞裂解液(Optilyse C)均为法国Immunotech公司出品。流式细胞仪(Epics XL·MCL)是美国BECKMAN  COULTER公司生产。 1.3  研究方法  使用直接免疫荧光标记全血溶血法,流式细胞仪测定肿瘤病人外周血淋巴细胞表面抗原表达。  

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥88
    上海优宁维生物科技股份有限公司
    2026年10月23日询价
    ¥3200
    爱必信(上海)生物科技有限公司
    2025年07月12日询价
    询价
    广州东锐科技有限公司
    2026年06月04日询价
    ¥22
    艾美捷科技有限公司
    2025年07月12日询价
    ¥1776
    苏州奕赛生物科技有限公司
    2026年05月01日询价
    Hu CD56 BV480 NCAM16.2 25Tst
    ¥3327